Pikumil Pikumil
Resultados de Pesquisa
Veja todos os resultados
  • Participar
    Entrar
    Registrar
    Pesquisar
    Night Mode

Pesquisar

Conheça novas pessoas, crie conexões e faça novos amigos

  • Feed de Notícias
  • EXPLORAR
  • Páginas
  • Grupos
  • Eventos
  • Reels
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Fóruns
  • Movies
  • Jogos
  • Publicações
  • Blogs
  • Usuários
  • Páginas
  • Grupos
  • Eventos
  • Subodh Adke adicionou um novo artigo Networking
    2026-05-05 11:46:01 -
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period.  (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....
    0 Comentários 0 Compartilhamentos 671 Visualizações 0 Anterior
    Faça Login para curtir, compartilhar e comentar!
  • Accrete Pharma adicionou um novo artigo Health
    2026-10-15 08:31:18 -
    Accrete Pharmaceuticals Private Limited – Bulk Drug Intermediates and Oncology Products
    Accrete Pharmaceuticals Private Limited is a company based in India that works with medicines that fight cancer and with materials used to make those medicines, including Imatinib Intermediate. The company focuses on making sure that everything it produces is of quality and that it knows a lot about the products it sells. It also likes to make sure that customers are happy. The company helps...
    0 Comentários 0 Compartilhamentos 17 Visualizações 0 Anterior
    Faça Login para curtir, compartilhar e comentar!
© 2026 Pikumil Portuguese
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Bengali
Sobre Termos Privacidade Fale Conosco Diretório